Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Docetaxel in First-Line Metastatic Breast Cancer
NCT00979641Phase 2Terminated
- Sponsor
- Tampere University Hospital
- Start
- Jan 2009
- Primary completion
- Dec 2014
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, docetaxel in breast cancer, sponsored by Tampere University Hospital. Started Jan 2009; status: terminated.
02
Drugs
bevacizumabdocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00979641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979641.